EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management of Recurrent Retroperitoneal Sarcoma

Joshua S Jolissaint iD, Chandrajit P Raut, Mark Fairweather

Current Oncology · 2023

DOI: 10.3390/curroncol30030209 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Joshua S Jolissaint und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Sarcoma, Liposarcoma, Leiomyosarcoma, Retroperitoneal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaLiposarcomaLeiomyosarcomaRetroperitoneal NeoplasmsSoft Tissue NeoplasmsHumansRetrospective StudiesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

recurrentretroperitonealsarcomasurgery

Autor:innen und Institutionen

  • Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Joshua S Jolissaint

Zitieren

APA

Jolissaint, J. S., Raut, C. P., & Fairweather, M. (2023). Management of Recurrent Retroperitoneal Sarcoma. Current Oncology. https://doi.org/10.3390/curroncol30030209

Vancouver

Jolissaint JS, Raut CP, Fairweather M. Management of Recurrent Retroperitoneal Sarcoma. Current Oncology. 2023. doi:10.3390/curroncol30030209

BibTeX
@article{Jolissaint2023,
  author = {Jolissaint, Joshua S and Raut, Chandrajit P and Fairweather, Mark},
  title = {Management of Recurrent Retroperitoneal Sarcoma},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30030209}
}
Kostenlos starten →